Theranostic and prognostic biomarkers: genomic applications in urological malignancies.

@article{Netto2010TheranosticAP,
  title={Theranostic and prognostic biomarkers: genomic applications in urological malignancies.},
  author={George J Netto and Jonathan I. Epstein},
  journal={Pathology},
  year={2010},
  volume={42 4},
  pages={384-94}
}
Compared to other solid tumours such as breast, colon, and lung, the current clinical management of urological malignancies is lagging behind in terms of utilisation of clinically robust molecular tests that can identify patients that are more likely to respond to a given targeted agent, or even those in need of a more aggressive treatment approach based on… CONTINUE READING